Biomedica 2012 - final brochure

Page 1

2012

The European Life Sciences Summit

Where Science & Business meet April 18-19, 2012 Liège, Belgium • Palais des Congrès

www.biomedicasummit.com The leading interdisciplinary congress in Life Sciences organised within the Top Technology Region of Belgium, Germany and The Netherlands

Organised by

With the support of


April 18-19, 2012 | Liège, Belgium

Biomedica at a glance History Biomedica started as an initiative of four Life Sciences associations being Bioliège, LifeTechLimburg, LifetecZONe and Lifetec Aachen-Jülich, representing the regions of Liège, Maastricht, Hasselt and Aachen.

Meanwhile Biomedica has grown into a leading conference in Medical Technology and Life Sciences within Belgium, The Netherlands and Germany (North Rhine Westphalia).

Summit figures Biomedica Summit welcomed participants not only from the Top Technology Region but also from other European countries, USA and Asia. 6th edition

2012

Liège, Belgium

1,200 participants expected !

5th edition

2011

Eindhoven, The Netherlands

1,100 participants

4th edition

2010

Aachen, Germany

950 participants

3rd edition

2009

Liège, Belgium

900 participants

2nd edition

2008

Maastricht, The Netherlands

800 participants

1st edition

2007

Aachen, Germany

460 participants

Locally present - practicing Globally

MÜLLER - FOTTNER - STEINECKE, a team of German and European Patent Attorneys is ranked among the most recommended intellectual property (IP) law firms in the field of Life Sciences in Germany. Our Office in Jülich is located in close vicinity to Aachen (Aix-la-chapelle), one of the main population centres of the transnational Euregio Maas-Rhine. Our second Office is located in Munich, seat of the European Patent Office, the German Patent and Trademark Office and the German Federal Patent Court. While our firm provides services in all technical fields, our major areas of expertise are biologics, antibody technology, pharmaceuticals, biosimilars, diagnostics, food technology and plant biotechnology. In these areas, our firm counsels biotechnology and pharmaceutical companies as well as Universities and research institutes in obtaining IP rights and defending against third party rights, e.g. in patent and trademark litigation, nullity proceedings, and opposition appeal proceedings. If you would like to arrange an appointment even on short notice, please call or email us. We can either meet you at the Biomedica or arrange for a meeting at your or our place. MÜLLER - FOTTNER - STEINECKE Patent Attorneys Attorneys at Law Römerstr. 16 b • Postfach / P.O. Box 11 40 • 52412 Jülich • Germany Tel. +49 (0)2461 341 18-0 • Fax +49 (0)2461 341 18-19 • info@ipbiotech.de 2

www.ipbiotech.de


www.biomedicasummit.com

Biomedica Summit 2012 When Science & Business meet Science:

Business:

find innovative partners from industry & universities to initiate joined R&D programmes for new products and applications

find innovative partners from industry & universities to initiate joined R&D programmes for new products and applications

learn how to build a career in the industry for medical technology & biotechnology

find opportunities for out/in licensing your know-how / find a golden business idea

present research results in the poster area

find researchers looking to join your R&D department at the Job fair

hear the latest breakthroughs obtained by university & industry research

hear the latest breakthroughs obtained by university & industry research

meet experts in one on one meetings during the Matchmaking event

meet experts in one on one meetings during the Matchmaking event

Key topics Biopharmaceuticals & nutraceuticals

Biomaterials

Session I: Inflammation

Session I: Biofunctional hydrogels

Session II: Endocrinology

Session II: Materials for musculoskeletal sport injury repair

Medical devices & care

Session I: Brain computer interfaces and neurological disease management

Session II: Image guided neuro interventions

Business development & product innovations The Lifetec Life Cycle

Session I: Starting-up a company

Session II: The companies operation

Session III: Company in growth

Session IV: Established company

Biomedica encompasses 50 Business & science presentations

A Job fair

5 Keynotes lectures

A Matchmaking event

100 Poster presentations

Valorisation of IP, Products & Services – VIPS corner

5-min’ Pitches Satellite conferences 2,000 m² Exhibition

Best poster award Collaboration award Cocktail reception & dinner

2012

The European Life Sciences Summit

3


April 18-19, 2012 | Liège, Belgium

More than a Conference

Poster competition & award

Collaboration award

Become a poster presenter at Biomedica 2012 or find a golden business idea !

This award is launched to promote industry-academia collaborations!

(PhD) Students will demonstrate new technologies and research results through a poster presentation

Poster presenters are explicitly asked to link research results to possibilities for commercialization

Collaborating companies and academic institutes/universities will be rewarded for innovative application oriented research or projects in the field of life sciences, medical technology or red and white biotechnology

Submit your poster before March 20th, 2012 Prize: EUR 500 (6 winners)

Send your summary before March 20th, 2012 Prize: EUR 10,000 (1 winner)

On April 18th, the Poster Jury will select 12 posters for oral presentations (on April 19th). The awards will be granted during the closing session.

Four nominees will present their project on April 18th and the winner will be granted on April 19th during the closing session.

5-min Pitches

Keynotes

All Biomedica participants can apply for a pitch:

4

Present your new technology, patent, product or service

Announce your request for partnerships/ cooperation

Ask for financial services or backing

Offer your services

Jean-Michel Saive – Table tennis champion, and supporting patients with cerebral palsy at «Les Coccinelles» (Liège, BE)

Prof. Dr. Sven Olaf Skouby – Session Biopharmaceuticals (University of Esbjerg, DK)

Prof. Dr. Richard Kitney – Session Medical devices (Imperial College, GB)

Prof. Dr. Bert Meijer – Session Biomaterials (Eindhoven University of Technology, NL)

Mr. Robert Dekker – Business Session (Tigenix, BE/NL)

Prof. Dr. Gordana Vunjak-Novakovic – sponsored Session Biomaterials (Columbia University, NY, USA)


www.biomedicasummit.com

More than an Exhibition Matchmaking event

Job fair

In collaboration with Enterprise Europe Network.

Find your future employer/employee at Biomedica 2012!

Find and meet potential partners and arrange one on one meetings with SME’s from Belgium, Germany and The Netherlands at the Summit. Access is free and open to all participants of the Summit. However, additional registration is required on www.biomedicasummit.com/specials

Find out how to build a career in the industry. Unique job opportunities will be presented within the exhibition area by:

companies and R&D institutes

HR representatives

recruiting companies

Access is free and open to all participants of the Summit. Prepare your visit and post your CV on www.vividlinks.eu

VIPS corner To stimulate Valorisation of Intellectual properties, Products and Services! The VIPS corner in Biomedica expo offers Technology Transfer Offices (TTO’s), Liaison offices or Valorisation offices of R&D institutes, Universities and Academic hospitals the opportunity to:

present available patents for licensing and show technology and services to industry representatives

build new relations with the industry and get engaged in cooperative research and development

Do not forget to visit the area!

2012

The European Life Sciences Summit

5


April 18-19, 2012 | Liège, Belgium

Programme Wednesday 18 April 08.30 - 09.30

Registration & Welcome coffee

09.30 - 09.40

Official Opening

09.40 - 09.50

Opening Biomedica by Prof. Dr. Bernard Rentier, Chair of Biomedica Foundation, Recteur, Chair of the board, University of Liège, Belgium

09.50 - 10.20

Keynote Presentation Mr. Jean-Michel Saive, Winner European Championship table tennis, one of three table tennis players at all Olympics, Supporter of association «Les Coccinelles», The centre A sport career and patients with cerebral palsy

10.20 - 11.00

Forum discussion - Cerebral palsy: improving living for disabled Participants: - Mr. Martial Paulus, Director Les Coccinelles, Home centre for adults with cerebral palsy, Liège, Belgium - Prof. Dr. Catherine Disselhorst-Klug, Head of department for rehabilitation & prevention engineering, Helmholz Institute Aachen, Germany - Prof. Dr. Yves Henrotin, Head of bone and cartillage research (U.R.O.C.), University of Liège, Belgium

11.00 - 11.30

Coffee break & Exhibition networking

11.00 - 13.45

MATCHMAKING EVENT

11.30 - 12.30

Biopharmaceuticals & nutraceuticals Session I (Part 1): Inflammation

Medical devices & care Session I (Part 1): Brain computer interfaces and neurological disease management

Chair: Prof. Dr. Sven Hendrix, Department of Anatomy and Cell Biology, Director of the Doctoral School for Medicine & Life Sciences, University of Hasselt, Belgium Co-chair: Dr. Bernard Coulie, CEO, ActoGeniX NV, Ghent, Belgium

Chair: Prof. Dr. Steven Laureys, Coma Science Group, Cyclotron Research Centre & Neurology Department, University of Liège, Belgium Co-chair: to be confirmed

11.30 - 11.55 Dr. Bernard Coulie, CEO, ActoGeniX NV, Ghent, Belgium ActoBiotics - A new class of biopharmaceuticals

11.30 - 11.55 Dr. Quentin Noirhomme, Coma Science Group, Cyclotron Research Centre, University of Liège, Belgium Brain-computer interface based diagnosis

11.55 - 12.20 Dr. Mario Losen, Department of Neuroscience, School of Mental Health and Neuroscience, Maastricht University, The Netherlands Immunotherapy of passive transfer myasthenia gravis in rhesus monkeys

11.55 - 12.20 Dr. Silke Musa, Department of Bio- and nanoelectronics, IMEC, Leuven, Belgium Integrated microsystems for probing the brain: status and outlook

12.30 - 13.45

Lunch break & Exhibition networking | Poster awards jury visits

13.45 - 14.30

Keynote Presentation BIOMATERIALS Prof. Dr. Bert Meijer, Institute for Complex Molecular Systems, Department of Chemical Engineering and Chemistry, Eindhoven University of Technology, The Netherland Supramolecular biomaterials; a modular approach to functional systems

14.30 - 15.30

Biopharmaceuticals & nutraceuticals Session I (Part 2): Inflammation

Medical devices & care Session I (Part 2): Brain computer interfaces and neurological disease management

Chair: Prof. Dr. Sven Hendrix, Department of Anatomy and Cell Biology, Director of the Doctoral School for Medicine & Life Sciences, University of Hasselt, Belgium Co-chair: Dr. Bernard Coulie, CEO, ActoGeniX NV, Ghent, Belgium

Chair: Prof. Dr. Steven Laureys, Coma Science Group, Cyclotron Research Centre & Neurology Dept, University of Liège, Belgium Co-chair: to be confirmed

14.30 - 15.00 Prof. Dr. Dirk Elewaut, Division of Rheumatology, University of Ghent, Belgium New insights in to the underlying mechanisms of inflammation in spondyloarthritis: a prototypic immune mediated inflammatory disorder

14.30 - 15.00 Dr. Christoph Guger, CEO, Gtec medical engineering GmbH, Schiedlberg, Austria Non-invasive and invasive BCI system application

15.00 - 15.30 Dr. Martin Sims, Research Director Apitope International NV, Hasselt, Belgium. Apitopes: improving treatment of autoimmune and allergic conditions through rational design of peptide epitopes

15.00 - 15.30 Dr. Febo Cincotti, Department of Clinical Neurophysiology, Neuroelectrical Imaging and BCI Lab, Santa Lucia Fondation, IRCCS, Rome, Italy Translational Issues for BCI in Neurorehabilitation

15.30 - 16.00

Coffee break & Exhibition networking

16.00 - 16.40

Keynote Presentation BIOPHARMACEUTICALS Prof. Dr. Sven Olaf Skouby, Director of Endocrinological and Reproductive Unit - Department Obstetrics and Gynecology Herlev Hospital, Faculty of Health Sciences, The Safety of Oral Contraception: new challenges

16.45 - 18.00

Biopharmaceuticals & nutraceuticals Session I (Part 3): Inflammation

Medical devices & care Session I (Part 3): Brain computer interfaces and neurological disease management

Chair: Prof. Dr. Sven Hendrix, Department of Anatomy and Cell Biology, Director of the Doctoral School for Medicine & Life Sciences, University of Hasselt, Belgium Co-chair: Dr. Bernard Coulie, CEO, ActoGeniX NV, Ghent, Belgium

Chair: Prof. Dr. Steven Laureys, Coma Science Group, Cyclotron Research Centre & Neurology Dept, University of Liège, Belgium Co-chair: to be confirmed

16.45 - 17.15 Prof. Dr. Orhan Aktas, Molecular Neurology Research Group, Heinrich-Heine University Hospital, Düsseldorf, Germany Evolution of multiple sclerosis treatment: next generation therapies meet next generation efficacy criteria

16.45 - 17.15 Prof. Dr. Robert Poirrier, Centre for Sleep Disorders, CHU, University of Liège, Belgium Sleep disorders and today technologies

17.15 - 17.45 Prof. Dr. Cornelis Kluft, Head of research, Good Biomarker Sciences, Leiden, The Netherlands Safety pharmacodynamics methods to assess inflammation and coagulation

17.15 - 17.45 Dr. Roy Raymann, Senior Scientist in Sleep, Secretary at Dutch Sleep Wake Society, Philips Research, Eindhoven, The Netherlands Supporting Sleep; Non-pharmacological interventions originating from neuro- and behavioral sciences

18.00 - 21.30

6

Transfer and Cocktail Reception & Dinner


www.biomedicasummit.com

e of life for adults with cerebral palsy in Liège

Biomaterials Session I (Part 1): Biofunctional hydrogels

The Lifetec Life Cycle Session I: Starting-up a company

Chair: Prof. Dr. Martin Möller, Director Institute for Technical and Macro-molecular Chemistry, Head of DWI, RWTH Aachen, Germany Co-chair: Prof. Dr. Christine Jérôme, Centre for Education and Research on Macromolecules, University of Liège, Belgium

Chair: Prof. Dr. Paul Borm, CEO, Nano4technology BV, Geleen, The Netherlands Co-chair: Mr. Jasper Levink, Consultant, Ttopstart BV, Eindhoven, The Netherlands

11.30 - 11.55 Prof. Dr. Jürgen Groll, Department of Functional Materials in Medicine and Dentistry, University of Würzburg, Germany Nanofiber-Hydrogel Composite-Structures for regenerative Medicine

11.30 - 11.50 Dr. Kurt Baeten, CSO MedicaSpec Diagnostics Bvba, Diepenbeek, Belgium Building a start-up: There is far more opportunity than there is ability

11.55 - 12.20 Prof. Dr. Alan Rowan, Noviotech BV, Nijmegen, The Netherlands Biomimetic Hydrogel Scaffolds and Extracellular Mimetic Materials - A Question of Stiffness

12.10 - 12.30 5-min Pitches (4 speakers)

Biomaterials Session I (Part 2): Biofunctional hydrogels

The Lifetec Life Cycle Session II: The companies operation

Chair: Prof. Dr. Martin Möller, Director Institute for Technical and Macro-molecular Chemistry, Head of DWI, RWTH Aachen, Germany Co-chair: Prof. Dr. Christine Jérôme, Centre for Education and Research on Macromolecules, University of Liège, Belgium

Chair: Mr. Peter Meijlink, Forte BV, The Netherlands Co-chair: Dr. Paulette Wauben, Senior Project Manager, NV Industriebank LIOF, Maastricht, The Netherlands

14.30 - 15.00 Prof. Dr. Doris Klee, ITMC, RWTH Aachen University, Germany Starshaped Polymeric Hydrogels for Biomedical Applications

14.30 - 14.50 Dr. Ir. Erwin Blomsma, CEO, Okapi Sciences NV, Leuven, Belgium Okapi Sciences: beyond the start, before the exit

11.50 - 12.10 Dr. Frank Bulens, Capricorn Health-tech Fund, Capricorn Venture Partners, Leuven, Belgium Getting a start-up company financed: some advices

ds

14.50 - 15.10 Mr. Ludovic Dornier, International Business Development, LC2, Lentilly, France Customization: Key to successful co-operation 15.00 - 15.30 Dr. Ir. Aart Molenberg, Director, Head of Biomaterials & Surfaces Research, Straumann AG, Basel, Switzerland Development of a Hydrogel Medical Device: Straumann® MembraGel

15.10 - 15.30 5-min Pitches (4 speakers)

University of Copenhagen and Department of Thrombosis Research, University of Esbjerg, Denmark Biomaterials Session I (Part 3): Biofunctional hydrogels

Collaboration Award session

Chair: Prof. Dr. Martin Möller, Director Institute for Technical and Macro-molecular Chemistry, Head of DWI, RWTH Aachen, Germany Co-chair: Prof. Dr. Christine Jérôme, Centre for Education and Research on Macromolecules, University of Liège, Belgium

Chair: Mrs Ria Hein, Brabantse Ontwikkelingsmaatschappij (BOM), Biomedica Board Member, The Netherlands

16.45 - 17.15 Dr. Dimitriya Bozukova, Project Leader Research & Development, QC Advisor, PhysIOL NV, Liège, Belgium Surface and bulk properties of hydrogels for intraocular lenses 17.15 - 17.45 Prof. Dr. Jennifer Patterson, Department of Metallurgy and Materials Engineering, KU Leuven, Belgium Biofunctionalization of Molecularly Engineered Hydrogels for an Enhanced Cellular Response

Nominee Award session Chair: Mrs Ria Hein - Introduction: - Nominee 1: - Nominee 2: - Nominee 3: - Nominee 4:

Mrs Ria Hein 17.00 -17.15 17.15 -17.30 17.30 -17.45 17.45 - 18.00

2012

The European Life Sciences Summit

7


April 18-19, 2012 | Liège, Belgium

Programme Thursday 19 April 08.30 - 09.30

Registration & Welcome coffee

09.30 - 10.10

Keynote Presentation MEDICAL DEVICES Prof. Dr. Richard Kitney, Imperial College, London, GB Title to be confirmed

11.15 - 11.15

Biopharmaceuticals & nutraceuticals Session II (Part 1): Endocrinology

Medical devices & care Session II (Part 1): Image guided neuro interventions

Chair: Prof. Dr. Herjan Coelingh Bennink, Former Medical Director and Head of Research at Organon, CEO of Pantarhei Bioscience BV, Zeist, The Netherlands Co-chair: Dr. Valérie Gordenne, Preclinical Research Director and Production Manager, Odyssea Pharma, Belgium

Chair: Prof. Dr. Hans Hofstraat, Philips Research, Eindhoven, The Netherlands Co-chair: Prof. Dr. Richard Kitney, Imperial College, London, GB

10.15 - 10.40 Prof. Dr. Albert Beckers, Chief Department of Endocrinology, CHU, University of Liège, Belgium The problems of orphan diseases: the example of FIPA (familial isolated pituitary adenoma), an orphan disease with well documented genetic aberrations but without therapeutic insights. New perspectives?

10.15 - 10.40 Prof. Dr. N. Jon Shah, Director of the Institute of Neuroscience and Medicine, Forschungszentrum Jülich, Germany Hybrid MR-PET Imaging at 9.4T: Challenges and Opportunities

10.40 - 11.05 Dr. Valérie Gordenne, Preclinical Research Director and Production Manager, Odyssea Pharma, Belgium The development of an intra-uterine device releasing controlled amounts of Levonorgestrel

10.40 - 11.05 Prof. Dr. Philippe A. Coucke, Department of Clinical Sciences, Radiotherapy, University of Liège, Belgium Robotic stereotactic radiosurgery and stereotactic body radiotherapy: How technical improvement does significantly influence outcome

11.05 - 11.15 Poster presentations (2)

11.05 - 11.15 Poster presentations (2)

11.15 - 11.45

Coffee break & Exhibition networking

11.30 - 14.00

MATCHMAKING EVENT

11.45 - 13.00

Biopharmaceuticals & nutraceuticals Session II (Part 2): Endocrinology

Medical devices & care Session II (Part 2): Image guided neuro interventions

Chair: Prof. Dr. Herjan Coelingh Bennink, Former Medical Director and Head of Research at Organon, CEO of Pantarhei Bioscience BV, Zeist, The Netherlands Co-chair: Dr. Valérie Gordenne, Preclinical Research Director and Production Manager, Odyssea Pharma, Belgium

Chair: Prof. Dr. Hans Hofstraat, Philips Research, Eindhoven, The Netherlands Co-chair: Prof. Dr. N. Jon Shah, Director of the Institute of Neuroscience and Medicine, Forschungszentrum Jülich, Germany

11.45 - 12.15 Prof. Dr. Jean-Michel Foidart, Head of Obstetric & Gynecologycal Department, CHU, ULg, Founder and CSO Uteron Pharma, Mythra, Liège, Belgium Estetrol : A recently described fetal estrogen with unique properties: development of contraceptive applications

11.45 - 12.15 Dr. Hubert Martens, Co-founder, Director of Clinical Sciences and Applications, Sapiens Steering Brain Stimulation BV, Eindhoven, The Netherlands Next generation electrodes for steering brain stimulation

12.15 - 12.45 Prof. Dr. Herjan Coelingh Bennink, Former Medical Director and Head of Research at Organon, CEO of Pantarhei Bioscience BV, Zeist, The Netherlands Estetrol use in postmenopausal women, protection of the breast

12.15 - 12.45 Dr. Dirk De Ridder, Founder of BRAI²N, Department of Neurosurgery, University Hospital Antwerp, Belgium Functional imaging guided electrode implantation for tinnitu

12.45 - 13.00 Poster presentations (2)

12.45 - 13.00 Poster presentations (2)

13.00 - 14.00

Lunch break & Exhibition networking

14.00 - 14.50

Biopharmaceuticals & nutraceuticals Session II (Part 3): Endocrinology

Medical devices & care Session II (Part 3): Image guided neuro interventions

Chair: Prof. Dr. Herjan Coelingh Bennink, Former Medical Director and Head of Research at Organon, CEO of Pantarhei Bioscience BV, Zeist, The Netherlands Co-chair: Dr. Valérie Gordenne, Preclinical Research Director and Production Manager, Odyssea Pharma, Belgium

Chair: Prof. Dr. Hans Hofstraat, Philips Research, Eindhoven, The Netherlands Co-chair: Dr. Dirk De Ridder, Founder of BRAI²N, Department of Neurosurgery, University Hospital Antwerp, Belgium

14.00 - 14.25 Prof. Dr. Andrea Genazzani, Director of the Department Obstetrics and Gynecology, President of the International Society of Gynecological Endocrinology, and of the European Society for Gynecologic and Obstetric Investigation, University of Pisa, Italy Independent Academic Investigations and Industrial constraints: an easy interaction?

14.00 - 14.25 Prof. Dr. Yasin Temel, Department of Neurosurgery, Maastricht University Medical Centre, Maastricht, The Netherlands Finding the right spot for deep brain stimulation in Parkinson’s disease

14.25 - 14.50 Dr. Nathalie Ledée, Head of research INSERM, Hopital St. Louis, Paris 7, France Follicular fluid G-CSF, a new noninvasive tool, for human embryo selection

14.25 - 14.50 Prof. Dr. Bart ter Haar Romeny, Biomedical Image Analysis (BMIA), Department of Biomedical Engineering, Eindhoven University of Technology, The Netherlands Visualization of structural and functional brain connectivity for neurosurgical applications

14.50 - 15.15

Coffee break & Exhibition networking

15.15 - 16.15

5-min Pitches in Plenary (12 speakers)

16.15 - 17.00

Keynote Presentation BIOMATERIALS (sponsored by Biomimedics) Prof. Dr. Gordana Vunjak-Novakovic, Mikati Foundation Professor of Biomedical Engineering, Vice-Chair & Professor of Biomedical Engineering and Medical Sciences (in M Cell-instructive biomaterials for tissue engineering and regenerative medicine

17.00 - 17.30

8

Collaboration award ceremony, poster awards & closing session


www.biomedicasummit.com

Biomaterials Session II (Part 1): Materials for musculoskeletal sport injury repair

The Lifetec Life Cycle Session III: Company in growth

Chair: Prof. Dr. Yves Henrotin, Head of Bone and Cartillage research (U.R.O.C.), University of Liège, Belgium Co-chair: Dr. Jean-François Stoltz, Department of Cell & Tissue Therapy, Brabois Hospital, University of Nancy, France

Chair: Dr. Bernward Garthoff, Clustermanager BIO.NRW, Düsseldorf, Germany Co-chair: Ir. John Paes, Chairman of Board of Commissioners, Technomed Europe, Maastricht-Airport, The Netherlands

10.15 - 10.40 Dr. Jean-François Stoltz, Department of Cell & Tissue Therapy, Brabois Hospital, University of Nancy, France Stem cells and cartillage repair: myth or reality

10.15 - 10.35 Dr. Vincent Larik, Managing Director, Applied Biomedical Systems, Maastricht, The Netherlands Approach to the market

10.40 - 11.05 Dr. Véronique Maquet, Kitozyme SA, Belgium Advances in biomaterials to repair cartilage

10.35 - 10.55 Dr. Alexander Vos, Pharmacell BV, Maastricht, The Netherlands How to organize cooperation between companies world wide

11.05 - 11.15 Poster presentations (2)

10.55 - 11.20 5-min Pitches (5 speakers)

Biomaterials Session II (Part 2): Materials for musculoskeletal sport injury repair

The Lifetec Life Cycle Session IV (Part 1): Established company

Chair: Prof. Dr. Yves Henrotin, Head of Bone and Cartillage research (U.R.O.C.), University of Liège, Belgium Co-chair: Dr. Jean-François Stoltz, Department of Cell & Tissue Therapy, Brabois Hospital, University of Nancy, France

Chair: Dr. Oliver Lehmkühler, Clustermanager MedizinTechnik NRW, Düsseldorf, Germany Co-chair: Dr. Ute Schelhaas, Agit GmbH, Aachen, Germany

11.45 - 12.15 Speaker and title to be confirmed

11.45 - 12.05 Dr. rer. pol. Michael Gebauer, CEO, CorTAG Molecular Diagnostics GmbH, Dortmund, Germany Strategy and future: Cardiogenetic Diagnostics

12.15 - 12.45 Prof. Dr. Daniel Saris, Co-director Biological Joint Reconstruction Research, President of the International cartilage repair society, University of Utrecht, The Netherlands Clinical evidence of cartilage repair efficacy

12.10 - 12.30 Mr. Robert Dekker, Manager IP & Business development, Tigenix, Leuven/ Geleen, Belgium/The Netherlands TiGenix, from idea to European leader in cell therapy

12.45 - 13.00 Poster presentations (2)

12.35 - 12.55 Dr. Bob Kool, CEO, Basic Pharma BV, Geleen, The Netherlands Challenges in a growing company

Biomaterials Session II (Part 3): Materials for musculoskeletal sport injury repair

The Lifetec Life Cycle Session IV (Part 2): Established company

Chair: Prof. Dr. Yves Henrotin, Head of Bone and Cartillage research (U.R.O.C.), University of Liège, Belgium Co-chair: Dr. Jean-François Stoltz, Department of Cell & Tissue Therapy, Brabois Hospital, University of Nancy, France

Chair: Dr. Oliver Lehmkühler, Clustermanager MedizinTechnik NRW, Düsseldorf, Germany Co-chair: Dr. Ute Schelhaas, Agit GmbH, Aachen, Germany

14.00 - 14.25 Prof. Dr. Liesbet Geris, Department of Aerospace and Mechanics, University of Liège, Belgium From mechanisms to therapy via mathematical models in fracture healing

14.00 - 14.15 Dr. Tolleiv Trimborn, CEO, Arcarios, Rotterdam, The Netherlands Realizing your exit

14.25 - 14.50 Prof. Dr. Madry Henning, Chair of Experimental Orthopaedics and Osteoarthritis Research, Saarland University Medical Center, Homburg/Saar, Germany Advances in techniques for meniscus repair

Satellite conference 1 (10.15 - 11.15)

Satellite conference 2 (11.45 - 12.45)

Satellite conference 3 (14.00 - 15.00)

14.15 - 14.30 Ir. Kees van Gorsel, AIM, Brunssum, The Netherlands Challenges between prototype and market introduction 14.30 - 14.45 Dr. Peter Brands, Research coordinator, Esaote Europe BV, Maastricht, The Netherlands Cooperation with academia: Innovations in Ultrasound imaging

Medicine), Director, Laboratory for Stem Cells and Tissue Engineering, Columbia University, NY, USA

2012

The European Life Sciences Summit

9


April 18-19, 2012 | Liège, Belgium

Confirmed sponsors & exhibitors 2012 Organised by

With the support of

Supporting universities

Diamond sponsors

Gold sponsors

Silver sponsors

Additional sponsors and exhibitors

Woman health, our future !

Matchmaking event partner

10

Job fair partners


www.biomedicasummit.com

Word from Mr. Mestrez, Deputy Province of Liège Biomedica – A Brainchild of Euregio Various Interreg projects from the Euregio Meuse-Rhine, like “Life Science” or “In Europa”, brought Life Science key players in the Euregio together and formed the basis for successful cooperation. By joining forces, tools and know-how and by integrating the potential of Leuven and Eindhoven, they created the “Top Technology Region” which has become a Life Science forefront in Europe and worldwide. Biomedica results from a fusion of several similar events in this region. Each year, it receives a financial support from the Euregio partner regions. So, we are proud to welcome the Event in Liège again, in 2012. It is an undeniable fact that our active companies in the domain of Biotechnology, mostly of University of Liège’s spin-offs, are augur well for the future development of the region. Let us give some examples of their important implication in the regional business structure: Jean-Pierre Delwart, the head of Eurogentec, was Chairman of the Walloon Business Union “Union Wallonne des Entreprises” for 3 years, and François Fornieri, Founder and administrator of Mithra Pharmaceuticals, a University of Liège spin off, has just won the title of Belgian Manager of the Year. Beside these flagships, there are so many other innovative and creative biotechnical companies. Let’s mention the “GIGA”, an interdisciplinary cluster for applied genoproteomics, whose concept has stirred up the international interest. It is a major pole of research and development for activities in the biotech area, promoting communication and interaction among various departments and faculties, as well as enhancing and relying on a close collaboration between research and business. Only a few similar centers in Europe have come so far in incorporating academic research, collaborations with companies and technology transfer centers. It’s impossible to ignore the “Liège Science Park”, under the responsibility of the Company-University Interface of the ULg, which is one of the partner organizers of Biomedica 2012. Several innovative companies are located in this business park, most of those spin-offs from ULg, have a close link to university research. Liège is very proud of its assets, and would like to welcome all participants. We invite them to participate and enjoy the city life, feel its quality of life and sense of hospitality. We hope they will return for the upcoming major events, like the Start of the Tour de France in June 2012, the Euroskills in October 2012 and, especially the International Exhibition in 2017. Have a nice stay and a good conference.

Julien Mestrez Deputy, Province of Liège Steering Committee member Euregio Meuse-Rhine

2012

The European Life Sciences Summit

11


Practical information Registration Register now on www.biomedicasummit.com Business delegate – 2 days

EUR 235 (excl. 21% VAT)

Business delegate – 1 day

EUR 175 (excl. 21% VAT)

Researcher / University delegate (2 days)

EUR 150 (excl. 21% VAT)

Student (2 days)

EUR 45 (excl. 21% VAT)

Hotels Hotels have been selected for the event. You can book hotel accommodation when registering online. Availability and rates guaranteed until February 29.

Evening dinner April 18 You can improve your network at Biomedica by attending the evening diner within the centre of Liège. The Biomedica evening dinner will be served at the Ballroom of the 5 ***** Crowne Plaza Liège, Les Comtes de Mean. This mansion originated from the 15th century, has been reconstructed into its original state and offers a Napoleon like atmosphere. From here you will have a breathtaking view on the city of Liège. Pont Atlas V

n

35 

at

Pont du Roi Albert I

iv

All information on « how to get there » on www.biomedicasummit.com/info

io

4020 Liège – Belgium

ér

Esplanade de l’Europe, 2

> E25 Maastricht

L

D

Palais des Congrès de Liège

se

eu

aM

> A602 Bruxelles Namur

Parc d’Avroy

La

Venue

Halles des Foires

Pont de Huy Gare TGV

Bd Raymond-Poincaré

Palais des Congrès

Sponsors & Exhibitors Interested in participating as a Sponsor or Exhibitor?

> E25 Ardennes

Contact Mandy Rizzo m.rizzo@biomedicasummit.eu

Vers E25

38 

Contact us For any questions or information contact Mindstream (Professional Congress Organiser) Av. Vésale 8c – 1300 Wavre – Belgium T : +32(0)10 22 40 83 – F : +32(0)10 24 70 48 liege2012@biomedicasummit.eu

This announcement has been printed with the support of

www.biomedicasummit.com

2012

The European Life Sciences Summit


Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.